Finance

Beta
Lists
ZLDPY:OTCMKTS
Zealand Pharma A S American Depository Receipt
$9.90
0.00%
(0.00) 1D
May 29, 10:12:22 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ZLDPY...
Mkt. cap
3.39B
Avg. vol.
157.00
Volume
0.00
52-wk high
$16.76
52-wk low
$7.75
Shares outstanding
357.63M
No. of employees
544
Mkt. cap
3.39B
Avg. vol.
157.00
Volume
0.00
52-wk high
$16.76
52-wk low
$7.75
Shares outstanding
357.63M
No. of employees
544
News stories
From sources across the web
Profile
Zealand Pharma A/S is a Danish biotechnology research company, which designs and develops peptide-based medicines, mainly focusing on metabolic diseases like diabetes and obesity. The company's head office is situated in Søborg near Copenhagen, and it has close to 200 employees. In 2018, they opened a subsidiary in the US. Zealand Pharma forms part of the Danish-Swedish life science cluster Medicon Valley. Wikipedia
About Zealand Pharma A S American Depository Receipt
CEOAdam Steensberg
Employees544
FoundedApr 1, 1997
Headquarters-
SectorBiotechnology
Websitezealandpharma.com
Previous reportsAll values in DKK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in DKK
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
9.09B
49.57M
68.92M
34.00M
Cost of goods sold
410.00K
-
-
-
Cost of revenue
410.00K
-
-
-
Research and development expenses
464.14M
320.04M
530.07M
469.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
110.46M
190.85M
91.81M
104.00M
Operating expense
749.45M
510.89M
621.88M
573.00M
Total operating expenses
749.86M
510.89M
621.88M
573.00M
Operating income
8.34B
-461.32M
-552.97M
-539.00M
Other non operating income
2.98M
-17.59M
-7.23M
24.00M
EBT including unusual items
8.11B
-366.73M
-406.51M
-394.00M
EBT excluding unusual items
8.11B
-383.62M
-460.20M
-375.00M
Income tax expense
537.32M
37.50M
-27.39M
-
Effective tax rate
6.62%
-10.23%
6.74%
-
Other operating expenses
174.85M
-
1.00K
-
Net income
7.57B
-404.23M
-379.12M
-394.00M
Net profit margin
83.33%
-815.50%
-550.12%
-1,158.82%
Earnings per share
105.61
-5.75
-5.19
-5.58
Interest and investment income
56.36M
108.95M
102.41M
74.00M
Interest expense
-7.34M
-7.00M
-7.07M
-5.00M
Net interest expenses
49.02M
101.95M
95.34M
69.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
8.34B
-454.10M
-550.48M
-529.00M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer